Učitavanje...
Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration
IMPORTANCE: While there have been multiple assessments of clinical trials leading to anticancer drug approvals by the US Food and Drug Administration (FDA), the cumulative percentage of approvals based on trials with a limitation remains uncertain. OBJECTIVE: To assess the percentage of clinical tri...
Spremljeno u:
| Izdano u: | JAMA Intern Med |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Medical Association
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7296449/ https://ncbi.nlm.nih.gov/pubmed/32539071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.2250 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|